Lumin UV System for Use in Nursing Homes, Ambulatory Care and Primary Care for SARS-CoV-2 N95 Re-Use Is Granted 3B Medical Emergency Use

December 4, 2020

Lumin UV system, has received Emergency Use Authorization from the FDA to permit use of the system, on N95 respirators during the COVID-19 pandemic.

Lumin UV system was designed to clean CPAP accessories but is also used as a multi-purpose sanitizer. Today’s announcement by the FDA allows Lumin to be used by healthcare workers employed in nursing homes, long term acute care, ambulatory, primary care, and clinics to allow N95 re-use to stop the spread of COVID-19 and help keep frontline healthcare workers safe.

UVC was first reportedly used for N95 decontamination during the COVID-19 crisis by the University of Nebraska Medical Center. Since then the CDC recognized UVC as a potential means of decontaminating N95 respirators if the proper wavelength and UVC irradiance dose were used. While the FDA has approved other systems for hospital use, the approved systems are complicated, limited to large hospitals, and/or extremely expensive. Lumin is the only N95 decontamination system formally recognized by FDA for killing SARS-CoV-2 that can be purchased for under $300, and with a small enough footprint to be used safely in small offices and clinics, as well as in nursing homes.

Alex Lucio, CEO of 3B Medical, Inc., said, “The COVID-19 global pandemic requires novel approaches and thinking outside the box.  We were starting to get inundated with calls from hospitals and nursing homes asking if Lumin was strong enough to kill SARS-CoV-2. Lumin’s total output in a single 5-minute cycle ranges up to  2,400 mJ/cm2, which studies show is sufficient to kill almost any pathogen, including SARS-CoV-2. A lot of the calls coming into our office are from Fire & Rescue departments, nursing homes, and smaller community hospitals, clinics, and primary care physician offices trying to keep their workers safe.”

He added, “Lumin is likely the only device designed for home use that is powered high enough to repurpose for this use. We are very excited to have our device authorized by FDA for this application”, concluded Lucio.

N95 mask shortages have been widely reported throughout the country, and globally. “Being able to re-use an N95 mask quickly and effortlessly is a game-changer for allowing healthcare workers to remain safe.  Front line healthcare workers are in dire need of an immediate solution to re-use their masks.  Lumin is fast and easy to use and we are glad the device could be re-purposed to meet that need in this crisis,” said Lucio.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy